You Position: Home > Paper

Therapeutic strategy for retinoblastoma in China

( views:498, downloads:329 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF OCULAR FUNDUS DISEASES
Issue:
2
DOI:
10.3760/cma.j.issn.1005-1015.2009.02.001
Key Word:
视网膜母细胞瘤/治疗;视网膜母细胞瘤/药物疗法;视网膜母细胞瘤/外科学;基因疗法;述评;Retinoblastoma/therapy;Retinoblastoma/drug therapy;Retinoblastoma/surgery;Gene therapy;Editorial

Abstract: Retinoblastoma (RB) is the most common intraocular malignant tumor in children. With advanced clinical technologies there are more and more methods available to treat retinoblastoma, and make it is possible to delivery individualized protocol combined traditional treatments with modern regimen to patients now. In order to improve the survival rate and the life quality of RB patients in China, it is very important to make a suitable system of standardized therapy based on results from developed countries and health policies of our own country.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn